HPV Testing and Pap Test Market Gains Momentum as Preventive Women’s Healthcare Takes Center Stage HPV Testing and Pap Test Market is witnessing steady expansion and is estimated to reach a multi-billion-dollar valuation over the forecast period, driven by the rising prevalence of cervical cancer, increasing adoption of preventive screening programs, and strong government initiatives...

The HPV testing and Pap test market is expanding as healthcare systems place greater emphasis on cervical cancer prevention, early diagnosis, and accessible screening. The market was valued at USD 3.6 billion in 2025 and is projected to grow from USD 3.8 billion in 2026 to USD 6.2 billion by 2033, registering a 7.2% CAGR from 2026 to 2033. Technological advancements in testing products, the...